A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk.
about
Polyunsaturated fatty acids in various macroalgal species from North Atlantic and tropical seasDetection and treatment of omega-3 fatty acid deficiency in psychiatric practice: Rationale and implementationEffects of ω3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled studyEffect of omega-3 fatty acid supplementation on cancer incidence, non-vascular death, and total mortality: a meta-analysis of randomized controlled trials.The effects of supplementation with omega-3 polyunsaturated Fatty acids on cardiac rhythm: anti-arrhythmic, pro-arrhythmic, both or neither? It depends…Association between the docosahexaenoic acid to arachidonic acid ratio and acute coronary syndrome: a multicenter observational study.Omega-3 index and cardiovascular health.Omega 3 fatty acids in the elderly.Long-chain omega-3 fatty acids: time to establish a dietary reference intake.Critical review of non-statin treatments for dyslipoproteinemia.Role of Omega-3 Fatty Acids in the Etiology, Treatment, and Prevention of Depression: Current Status and Future Directions.ω3-Polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4.Does Supplementation with Omega-3 PUFAs Add to the Prevention of Cardiovascular Disease?Enriching Diet with n-3 PUFAs to Help Prevent Cardiovascular Diseases in Healthy Adults: Results from Clinical Trials.Mente Activa® Improves Impaired Spatial Memory in Aging Rats.No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial.Effects of Omega-3 Long Chain Polyunsaturated Fatty Acid Supplementation on Cardiovascular Mortality: The Importance of the Dose of DHA.Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.
P2860
Q21245698-2AA88333-2DD2-4EC0-8A9B-84C5B1DE1645Q28066354-749FABEA-D15C-446C-A676-748F19107557Q33820362-1946B21B-4B30-4E46-AD8D-8E9452A91B43Q35102695-C27741EF-EB6A-4089-A569-1A40EEF598C9Q35865078-037C8876-1870-427D-8D22-14385A79DA04Q36069778-9EA974FA-F35A-4936-82EE-EEF64819805DQ37617749-D175A06B-3C4D-4D8B-8CF7-51621B0A8EF4Q38010553-B600C85E-6773-4589-960E-E560BD3AAAF8Q38151841-D7586B70-F0A5-47D3-B116-99A425B13A7DQ38186099-E6794D5B-FA5D-469A-AE22-6A5BE23FE207Q38808320-92350A10-0456-439A-B488-B1C05DD02E17Q39041784-0FE1D179-F5D3-47A4-B2B2-4DA8C2F84272Q39255894-F5759152-D3CA-4FE7-AC4D-337E9223B92AQ39441530-578549E1-A86C-4AA7-AE3F-4C364CB24CEFQ40494042-29B490E9-3B1D-47B9-8644-9D5648C063D8Q45186149-8BCF1230-DF62-447F-98EA-973174CB10ACQ47168426-55F6C065-5243-43F3-8CD9-2FA40C6882B1Q48517326-B9F11FBF-27A1-46D7-AAAF-D3A414AEBEB5
P2860
A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
A randomized clinical trial on ...... n at high cardiovascular risk.
@en
A randomized clinical trial on ...... n at high cardiovascular risk.
@nl
type
label
A randomized clinical trial on ...... n at high cardiovascular risk.
@en
A randomized clinical trial on ...... n at high cardiovascular risk.
@nl
prefLabel
A randomized clinical trial on ...... n at high cardiovascular risk.
@en
A randomized clinical trial on ...... n at high cardiovascular risk.
@nl
P2093
P2860
P1476
A randomized clinical trial on ...... n at high cardiovascular risk.
@en
P2093
Elsa M Hjerkinn
Gunnar Einvik
Tor Ole Klemsdal
P2860
P304
P356
10.1097/HJR.0B013E328339CC70
P50
P577
2010-10-01T00:00:00Z